Multiple Sclerosis Clinical Trial
Optical Coherence Tomography in Multiple Sclerosis Patients
Summary
To evaluate the ability of different spectral domain optical coherence tomography (OCT) devices, as well as different acquisition and analysis packages, to detect disease progression in patients with multiple sclerosis with and without a history of optic neuritis
Full Description
Optical coherence tomography imaging of the retina has been shown to be an effective non invasive method to study retinal changes associated with multiple sclerosis induced optic neuritis. The retina is a unique structure in that it is an unmyelinated part of the central nervous system (CNS). However, it is uncertain which layer of the retina provides the best correlation with MS disease. The investigators propose a prospective, case-control study to compare OCT measurements from different parts of the retina of MS patients with optic neuritis, those without optic neuritis, and healthy controls. The investigators will then correlate the OCT measurements to clinical measures of disease. This will allow future studies to use OCT technology as a primary outcome in studying MS axonal and cell body injury of the CNS, as well as evaluating strategies in treating MS.
Eligibility Criteria
Inclusion criteria (MS with acute optic neuritis group):
History of unilateral optic neuritis as a manifestation of multiple sclerosis.
Age between 18 and 65, inclusive.
Ability to perform adequate OCT exam.
Able to provide informed consent to participate in study.
Exclusion criteria (MS with acute optic neuritis group):
- Refractive error greater than ±6 diopters.
Inclusion criteria (MS without acute optic neuritis group):
History of multiple sclerosis without optic neuritis
Age between 18 and 65, inclusive.
Ability to perform adequate OCT exam.
Able to provide informed consent to participate in study.
Exclusion criteria (MS without acute optic neuritis group):
- Refractive error greater than ±6 diopters.
Inclusion criteria (healthy controls):
Age between 18 and 65, inclusive.
Ability to perform adequate OCT exam.
Able to provide informed consent to participate in the study.
Exclusion criteria (healthy controls):
Prior history of neurological disease.
First degree relative with MS.
Refractive error greater than ±6 diopters.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Cleveland Ohio, 44195, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.